PharmaShots’ Key Highlights of First Quarter 2024

Shots: The first quarter of 2024 highlights major acquisitions in the pharma and biotech industry along with clinical trial results and approvals. The highlight of the quarter was Gilead's acquisition of CymaBay Therapeutics for an aggregate of ~$4.3B This quarter also showcased multiple clinical trial results including Axsome Therapeutics P-III results for AXS-12 and BMS'…

BySenior EditorApril 1, 2024

TOP 20

Top 20 Animal Health Companies Based on 2019 Revenue

Healthy animals contribute to the elimination of hunger and sustainable food production. The diseases that affect animal health also affect humans. Tackling them while they are present in animals not only safeguards our health- but it is also easier- more effective- and less expensive to address. Monitoring animal health and preventing animal disease outbreaks is…

ByPrince GiriNovember 12, 2020

PharmaShots’ Key Highlights of First Quarter 2024

Top 20 Animal Health Companies Based on 2019 Revenue

Contact US

FOLLOW US